{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:46:33Z","timestamp":1787312793134,"version":"build-2736575974"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004478","name":"Beijing Union University","doi-asserted-by":"publisher","award":["ZKZD202304"],"award-info":[{"award-number":["ZKZD202304"]}],"id":[{"id":"10.13039\/501100004478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05329-y","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T08:14:31Z","timestamp":1762935271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Synergistic Role of ApoE4 and GSK3\u03b2 in Alzheimer\u2019s Disease: Pathological Mechanisms and Therapeutic Implications"],"prefix":"10.1007","volume":"63","author":[{"given":"Qianwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5997-7137","authenticated-orcid":false,"given":"Fengxue","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"3","key":"5329_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.apsb.2022.01.008","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Xu C, Sun J, Shen H-M, Wang J, Yang C (2022) Impairment of the autophagy\u2013lysosomal pathway in Alzheimer\u2019s diseases: pathogenic mechanisms and therapeutic potential. Acta Pharm Sin B 12(3):1019\u20131040. https:\/\/doi.org\/10.1016\/j.apsb.2022.01.008","journal-title":"Acta Pharm Sin B"},{"key":"5329_CR2","doi-asserted-by":"publisher","unstructured":"Muth C, Hartmann A, Sepulveda-Falla D, Glatzel M, Krasemann S (2019) Phagocytosis of apoptotic cells is specifically upregulated in ApoE4 expressing microglia in vitro. Orig Res 13. https:\/\/doi.org\/10.3389\/fncel.2019.00181","DOI":"10.3389\/fncel.2019.00181"},{"issue":"4","key":"5329_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3233\/jad-130920","volume":"38","author":"KTS Wirz","year":"2013","unstructured":"Wirz KTS, Keitel S, Swaab DF, Verhaagen J, Bossers K (2013) Early molecular changes in Alzheimer disease: can we catch the disease in its presymptomatic phase? J Alzheimers Dis 38(4):719\u2013740. https:\/\/doi.org\/10.3233\/jad-130920","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"5329_CR4","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189\u2013a006189. https:\/\/doi.org\/10.1101\/cshperspect.a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5329_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100281","volume":"296","author":"S Devkota","year":"2021","unstructured":"Devkota S, Williams TD, Wolfe MS (2021) Familial Alzheimer\u2019s disease mutations in amyloid protein precursor alter proteolysis by \u03b3-secretase to increase amyloid \u03b2-peptides of \u226545 residues. J Biol Chem 296:100281. https:\/\/doi.org\/10.1016\/j.jbc.2021.100281","journal-title":"J Biol Chem"},{"key":"5329_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27041210","author":"C Ma","year":"2022","unstructured":"Ma C, Hong F, Yang S (2022) Amyloidosis in Alzheimer\u2019s disease: pathogeny, etiology, and related therapeutic directions. Molecules. https:\/\/doi.org\/10.3390\/molecules27041210","journal-title":"Molecules"},{"issue":"3","key":"5329_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/13506120701460923","volume":"14","author":"P Westermark","year":"2007","unstructured":"Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S-I, Masters CL, Merlini G et al (2007) A primer of amyloid nomenclature. Amyloid 14(3):179\u2013183. https:\/\/doi.org\/10.1080\/13506120701460923","journal-title":"Amyloid"},{"issue":"6","key":"5329_CR8","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","volume":"177","author":"MS Ioannou","year":"2019","unstructured":"Ioannou MS, Jackson J, Sheu S-H, Chang C-L, Weigel AV, Liu H, Pasolli HA, Xu CS et al (2019) Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell 177(6):1522\u20131535. https:\/\/doi.org\/10.1016\/j.cell.2019.04.001","journal-title":"Cell"},{"issue":"3","key":"5329_CR9","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s11357-024-01118-y","volume":"46","author":"M Pszczo\u0142owska","year":"2024","unstructured":"Pszczo\u0142owska M, Walczak K, Mi\u015bk\u00f3w W, Mroziak M, Chojdak-\u0141ukasiewicz J, Leszek J (2024) Mitochondrial disorders leading to Alzheimer\u2019s disease-perspectives of diagnosis and treatment. GeroScience 46(3):2977\u20132988. https:\/\/doi.org\/10.1007\/s11357-024-01118-y","journal-title":"GeroScience"},{"key":"5329_CR10","doi-asserted-by":"publisher","unstructured":"Liang LL, He MF, Zhou PP, Pan SK, Liu DW, Liu ZS (2024) GSK3\u03b2: a ray of hope for the treatment of diabetic kidney disease. FASEB J 38(3):e23458\u2013e23458. https:\/\/doi.org\/10.1096\/fj.202302160R","DOI":"10.1096\/fj.202302160R"},{"issue":"7","key":"5329_CR11","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/j.celrep.2018.04.045","volume":"23","author":"SA Martin","year":"2018","unstructured":"Martin SA, Souder DC, Miller KN, Clark JP, Sagar AK, Eliceiri KW, Puglielli L, Beasley TM et al (2018) GSK3\u03b2 regulates brain energy metabolism. Cell Rep 23(7):1922\u20131931. https:\/\/doi.org\/10.1016\/j.celrep.2018.04.045","journal-title":"Cell Rep"},{"issue":"1","key":"5329_CR12","first-page":"11","volume":"33","author":"VI Zannis","year":"1981","unstructured":"Zannis VI, Just PW, Breslow JL (1981) Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 33(1):11\u201324","journal-title":"Am J Hum Genet"},{"issue":"9","key":"5329_CR13","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1002\/alz.14173","volume":"20","author":"YJ Zhang","year":"2024","unstructured":"Zhang YJ, Cheng Y, Tang HL, Yue Q, Cai XY, Lu ZJ, Hao YX, Dai AX et al (2024) APOE \u03b54\u2013associated downregulation of the IL-7\/IL-7R pathway in effector memory T cells: implications for Alzheimer\u2019s disease. Alzheimers Dement 20(9):6441\u20136455. https:\/\/doi.org\/10.1002\/alz.14173","journal-title":"Alzheimers Dement"},{"issue":"S2","key":"5329_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/alz.067916","volume":"19","author":"J Bae","year":"2023","unstructured":"Bae J, Nho K, Saykin AJ, Penchev V, Apostolova LG (2023) Unbiased deep learning assessment of APOE4 risk for sporadic Alzheimer\u2019s disease. Alzheimers Dement 19(S2):e067916. https:\/\/doi.org\/10.1002\/alz.067916","journal-title":"Alzheimers Dement"},{"issue":"3","key":"5329_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/1873-3468.14803","volume":"598","author":"H Matsuura","year":"2024","unstructured":"Matsuura H, Akahane S, Kaido T, Kamijo T, Sakamoto K, Yamauchi K (2024) Apolipoprotein E isoforms and their Cys-thiol modifications impact LRP1-mediated metabolism of triglyceride-rich lipoproteins. FEBS Lett 598(3):347\u2013362. https:\/\/doi.org\/10.1002\/1873-3468.14803","journal-title":"FEBS Lett"},{"issue":"1","key":"5329_CR16","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41598-020-59869-5","volume":"10","author":"JS Friedberg","year":"2020","unstructured":"Friedberg JS, Aytan N, Cherry JD, Xia W, Standring OJ, Alvarez VE, Nicks R, Svirsky S et al (2020) Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E \u03b54 genotype. Sci Rep 10(1):2924. https:\/\/doi.org\/10.1038\/s41598-020-59869-5","journal-title":"Sci Rep"},{"key":"5329_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjad075","author":"J Zhang","year":"2023","unstructured":"Zhang J, Yang S-G, Zhou F-Q (2023) Glycogen synthase kinase 3 signaling in neural regeneration in vivo. J Mol Cell Biol. https:\/\/doi.org\/10.1093\/jmcb\/mjad075","journal-title":"J Mol Cell Biol"},{"issue":"2","key":"5329_CR18","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/med.21867","volume":"42","author":"L Wang","year":"2021","unstructured":"Wang L, Li J, Di Lj (2021) Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases. Med Res Rev 42(2):946\u2013982. https:\/\/doi.org\/10.1002\/med.21867","journal-title":"Med Res Rev"},{"issue":"S8","key":"5329_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/alz.095568","volume":"20","author":"B Pinho","year":"2025","unstructured":"Pinho B, Vaz M, Martins TS, da Cruz e Silva O, Henriques AG (2025) GSK3\u03b1 levels in Alzheimer\u2019s disease mimicking models. Alzheimers Dement 20(S8):e095568. https:\/\/doi.org\/10.1002\/alz.095568","journal-title":"Alzheimers Dement"},{"issue":"6791","key":"5329_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35017574","volume":"406","author":"KP Hoeflich","year":"2000","unstructured":"Hoeflich KP, Luo J, Rubie EA, Tsao M-S, Jin O, Woodgett JR (2000) Requirement for glycogen synthase kinase-3\u03b2 in cell survival and NF-\u03baB activation. Nature 406(6791):86\u201390. https:\/\/doi.org\/10.1038\/35017574","journal-title":"Nature"},{"issue":"D1","key":"5329_CR21","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, Wu J, Tang H et al (2025) Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic acids research 53(D1):D1670\u2013D1676. https:\/\/doi.org\/10.1093\/nar\/gkae973","journal-title":"Nucleic acids research"},{"issue":"1","key":"5329_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/circresaha.124.325187","volume":"136","author":"L Wang","year":"2024","unstructured":"Wang L, Li J, Tang P, Zhu D, Tai L, Wang Y, Miyata T, Woodgett JR, Di L-J (2024) GSK3\u03b2 deficiency expands obese adipose vasculature to mitigate metabolic disorders. Circ Res 136(1):91\u2013111. https:\/\/doi.org\/10.1161\/circresaha.124.325187","journal-title":"Circ Res"},{"issue":"7","key":"5329_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14818","volume":"30","author":"J Zhao","year":"2024","unstructured":"Zhao J, Wei M, Guo M, Wang M, Niu H, Xu T, Zhou Y (2024) GSK3: a potential target and pending issues for treatment of Alzheimer\u2019s disease. CNS Neurosci Ther 30(7):e14818. https:\/\/doi.org\/10.1111\/cns.14818","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"5329_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","volume":"147","author":"DP Hanger","year":"1992","unstructured":"Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH (1992) Glycogen synthase kinase-3 induces Alzheimer\u2019s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147(1):58\u201362. https:\/\/doi.org\/10.1016\/0304-3940(92)90774-2","journal-title":"Neurosci Lett"},{"issue":"19","key":"5329_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911610","volume":"23","author":"L Song","year":"2022","unstructured":"Song L, Oseid DE, Wells EA, Robinson AS (2022) The interplay between GSK3\u03b2 and tau Ser262 phosphorylation during the progression of tau pathology. Int J Mol Sci 23(19):11610. https:\/\/doi.org\/10.3390\/ijms231911610","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5329_CR26","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/hmg\/ddy017","volume":"27","author":"F Fang","year":"2018","unstructured":"Fang F, Yu Q, Arancio O, Chen D, Gore SS, Yan SS, Yan SF (2018) RAGE mediates A\u03b2 accumulation in a mouse model of Alzheimer\u2019s disease via modulation of \u03b2- and \u03b3-secretase activity. Hum Mol Genet 27(6):1002\u20131014. https:\/\/doi.org\/10.1093\/hmg\/ddy017","journal-title":"Hum Mol Genet"},{"issue":"1","key":"5329_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3892\/ijmm.2019.4198","volume":"44","author":"J Chen","year":"2019","unstructured":"Chen J, Long Z, Li Y, Luo M, Luo S, He G (2019) Alteration of the Wnt\/GSK3\u03b2\/\u03b2-catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer\u2019s disease model. Int J Mol Med 44(1):313\u2013323. https:\/\/doi.org\/10.3892\/ijmm.2019.4198","journal-title":"Int J Mol Med"},{"issue":"529","key":"5329_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1809","volume":"12","author":"N Zhao","year":"2020","unstructured":"Zhao N, Attrebi ON, Ren Y, Qiao W, Sonustun B, Martens YA, Meneses AD, Li F et al (2020) APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid. Sci Transl Med 12(529):1809. https:\/\/doi.org\/10.1126\/scitranslmed.aay1809","journal-title":"Sci Transl Med"},{"key":"5329_CR29","doi-asserted-by":"publisher","unstructured":"Zhao N, Liu C-C, Van Ingelgom AJ, Martens YA, Linares C, Knight JA, Painter MM, Sullivan PM, Bu G (2017) Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron 96(4):115\u2013129. https:\/\/doi.org\/10.1016\/j.neuron.2017.09.003","DOI":"10.1016\/j.neuron.2017.09.003"},{"issue":"7365","key":"5329_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature10383","volume":"477","author":"JH Choi","year":"2011","unstructured":"Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, Kumar N, Kuruvilla DS, Shin Y (2011) Antidiabetic actions of a non-agonist PPAR\u03b3 ligand blocking Cdk5-mediated phosphorylation. Nature 477(7365):477\u2013481. https:\/\/doi.org\/10.1038\/nature10383","journal-title":"Nature"},{"issue":"48","key":"5329_CR31","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1523\/jneurosci.1400-19.2019","volume":"39","author":"V Rawat","year":"2019","unstructured":"Rawat V, Wang S, Sima J, Bar R, Liraz O, Gundimeda U, Parekh T, Chan J et al (2019) ApoE4 alters ABCA1 membrane trafficking in astrocytes. J Neurosci 39(48):9611\u20139622. https:\/\/doi.org\/10.1523\/jneurosci.1400-19.2019","journal-title":"J Neurosci"},{"issue":"7","key":"5329_CR32","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s11064-020-03031-0","volume":"45","author":"TT Nguyen","year":"2020","unstructured":"Nguyen TT, Ta QTH, Nguyen TTD, Le TT, Vo VG (2020) Role of insulin resistance in the Alzheimer\u2019s disease progression. Neurochem Res 45(7):1481\u20131491. https:\/\/doi.org\/10.1007\/s11064-020-03031-0","journal-title":"Neurochem Res"},{"issue":"10","key":"5329_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.70056","volume":"14","author":"Z Kai-Xin","year":"2024","unstructured":"Kai-Xin Z, Ning S, Peng-Li D, Ji-Wei Z, Xiang-Qing X, Ya-Han W (2024) Danggui Shaoyao San alleviates early cognitive impairment in Alzheimer\u2019s disease mice through IRS1\/GSK3\u03b2\/Wnt3a-\u03b2-catenin pathway. Brain and Behavior 14(10):e70056. https:\/\/doi.org\/10.1002\/brb3.70056","journal-title":"Brain and Behavior"},{"key":"5329_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101644","author":"S Liao","year":"2020","unstructured":"Liao S, Wu J, Liu R, Wang S, Luo J, Yang Y, Qin Y, Li T et al (2020) A novel compound DBZ ameliorates neuroinflammation in LPS-stimulated microglia and ischemic stroke rats: role of Akt(Ser473)\/GSK3\u03b2(Ser9)-mediated Nrf2 activation. Redox Biol. https:\/\/doi.org\/10.1016\/j.redox.2020.101644","journal-title":"Redox Biol"},{"key":"5329_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103339","volume":"76","author":"A Sanz-Alc\u00e1zar","year":"2024","unstructured":"Sanz-Alc\u00e1zar A, Portillo-Carrasquer M, Delaspre F, Pazos-Gil M, Tamarit J, Ros J, Cabiscol E (2024) Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1\/AMPK, KEAP1, and GSK3\u03b2 in the impairment of the NRF2 response. Redox Biol 76:103339. https:\/\/doi.org\/10.1016\/j.redox.2024.103339","journal-title":"Redox Biol"},{"issue":"13","key":"5329_CR36","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/sj.emboj.7600251","volume":"23","author":"L Baki","year":"2004","unstructured":"Baki L, Shioi J, Wen P, Shao Z, Schwarzman A, Gama-Sosa M, Neve R, Robakis NK (2004) PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J 23(13):2586\u20132596. https:\/\/doi.org\/10.1038\/sj.emboj.7600251","journal-title":"EMBO J"},{"key":"5329_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.biochem.70.1.535","volume":"70","author":"B Vanhaesebroeck","year":"2001","unstructured":"Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ et al (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535\u2013602. https:\/\/doi.org\/10.1146\/annurev.biochem.70.1.535","journal-title":"Annu Rev Biochem"},{"issue":"6559","key":"5329_CR38","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DAE Cross","year":"1995","unstructured":"Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378(6559):785\u2013789. https:\/\/doi.org\/10.1038\/378785a0","journal-title":"Nature"},{"key":"5329_CR39","doi-asserted-by":"publisher","unstructured":"Wang L, Li J, Tang P, Zhu D, Tai L, Wang Y, Miyata T, Woodgett JR, Di L-J (2024) GSK3\u03b2 deficiency expands obese adipose vasculature to mitigate metabolic disorders. Circ Res 136. https:\/\/doi.org\/10.1161\/circresaha.124.325187","DOI":"10.1161\/circresaha.124.325187"},{"issue":"12","key":"5329_CR40","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.2337\/db11-1735","volume":"61","author":"SM Son","year":"2012","unstructured":"Son SM, Song H, Byun J, Park KS, Jang HC, Park YJ, Mook-Jung I (2012) Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway. Diabetes 61(12):3126\u20133138. https:\/\/doi.org\/10.2337\/db11-1735","journal-title":"Diabetes"},{"issue":"4","key":"5329_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1478-3231.2009.02200.x","volume":"30","author":"LdF Pinto","year":"2010","unstructured":"Pinto LdF, Compri CM, Fornari JV, Bartchewsky W, Cintra DE, Trevisan M, Carvalho PdO, Ribeiro ML et al (2010) The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. Liver Int 30(4):603\u2013610. https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02200.x","journal-title":"Liver Int"},{"issue":"4","key":"5329_CR42","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.fob.2014.02.011","volume":"28","author":"Q-R Ong","year":"2014","unstructured":"Ong Q-R, Chan ES, Lim M-L, Wong B-S (2014) Expression of human apolipoprotein E4 reduces insulin-receptor substrate 1 expression and Akt phosphorylation in the ageing liver. FEBS Open Bio 28(4):260\u2013265. https:\/\/doi.org\/10.1016\/j.fob.2014.02.011","journal-title":"FEBS Open Bio"},{"issue":"5","key":"5329_CR43","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00424-024-02933-0","volume":"476","author":"HM Moghazy","year":"2024","unstructured":"Moghazy HM, Abdelhaliem NG, Mohammed SA, Hassan A, Abdelrahman A (2024) Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K\/AKT\/GSK-3\u03b2\/TTBK1 pathway and decreasing tau hyperphosphorylation in high-fat diet- streptozocin rat model. Pfl\u00fcgers Arch Eur J Physiol 476(5):779\u2013795. https:\/\/doi.org\/10.1007\/s00424-024-02933-0","journal-title":"Pfl\u00fcgers Arch Eur J Physiol"},{"issue":"2","key":"5329_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14384","volume":"24","author":"G Lisa","year":"2024","unstructured":"Lisa G, Uwe R, Andreas R, Heike B, Andreas B, S\u00fcleyman E, Florian K (2024) Vascular inflammaging: endothelial CEACAM1 expression is upregulated by TNF-\u03b1 via independent activation of NF-\u03baB and \u03b2-catenin signaling. Aging Cell 24(2):e14384. https:\/\/doi.org\/10.1111\/acel.14384","journal-title":"Aging Cell"},{"issue":"5","key":"5329_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1089\/jmf.2023.k.0326","volume":"27","author":"J Lee","year":"2024","unstructured":"Lee J, Park J, Song K-M, Lee YG, Choi H-K (2024) Actinidia arguta extract containing myo-inositol suppresses TNF-\u03b1-induced VCAM-1 expression and monocyte adhesion to endothelial cells via inhibition of the PTEN\/Akt\/GSK-3\u03b2 and NF-\u03baB signaling pathways. J Med Food 27(5):419\u2013427. https:\/\/doi.org\/10.1089\/jmf.2023.k.0326","journal-title":"J Med Food"},{"key":"5329_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neurobiolaging.2019.10.013","volume":"86","author":"JA Contreras","year":"2020","unstructured":"Contreras JA, Aslanyan V, Sweeney MD, Sanders LMJ, Sagare AP, Zlokovic BV, Toga AW, Han SD et al (2020) Functional connectivity among brain regions affected in Alzheimer\u2019s disease is associated with CSF TNF-\u03b1 in APOE4 carriers. Neurobiol Aging 86:112\u2013122. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.10.013","journal-title":"Neurobiol Aging"},{"issue":"4","key":"5329_CR47","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/pro.3122","volume":"26","author":"FH Tran","year":"2017","unstructured":"Tran FH, Zheng JJ (2017) Modulating the wnt signaling pathway with small molecules. Protein Sci 26(4):650\u2013661. https:\/\/doi.org\/10.1002\/pro.3122","journal-title":"Protein Sci"},{"issue":"7","key":"5329_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/psc.3389","volume":"28","author":"X Wang","year":"2021","unstructured":"Wang X, Dong L, Cheng J, Verdine GL, Lin A, Chu Q (2021) Targeted \u03b2-catenin ubiquitination and degradation by multifunctional stapled peptides. J Pept Sci 28(7):e3389. https:\/\/doi.org\/10.1002\/psc.3389","journal-title":"J Pept Sci"},{"issue":"5","key":"5329_CR49","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"196","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H (2017) Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 196(5):985\u2013999. https:\/\/doi.org\/10.1016\/j.cell.2017.05.016","journal-title":"Cell"},{"issue":"3","key":"5329_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41419-018-0359-6","volume":"9","author":"X-F Liu","year":"2018","unstructured":"Liu X-F, Li X-Y, Zheng P-S, Yang W-T (2018) DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt\/\u03b2-catenin pathway via GSK3\u03b2. Cell Death Dis 9(3):339. https:\/\/doi.org\/10.1038\/s41419-018-0359-6","journal-title":"Cell Death Dis"},{"issue":"11","key":"5329_CR51","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1007\/s11064-024-04224-7","volume":"49","author":"E Col\u00edn-Mart\u00ednez","year":"2024","unstructured":"Col\u00edn-Mart\u00ednez E, Espino-de-la-Fuente C, Arias C (2024) Age- and sex-associated Wnt signaling dysregulation is exacerbated from the early stages of neuropathology in an Alzheimer\u2019s disease model. Neurochem Res 49(11):3094\u20133104. https:\/\/doi.org\/10.1007\/s11064-024-04224-7","journal-title":"Neurochem Res"},{"issue":"2","key":"5329_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1042\/bj3290209","volume":"329","author":"TC Dale","year":"1998","unstructured":"Dale TC (1998) Signal transduction by the Wnt family of ligands. Biochem J 329(2):209\u2013223. https:\/\/doi.org\/10.1042\/bj3290209","journal-title":"Biochem J"},{"key":"5329_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00164","volume":"10","author":"M Huang","year":"2018","unstructured":"Huang M, Liang Y, Chen H, Xu B, Chai C, Xing P (2018) The role of fluoxetine in activating Wnt\/\u03b2-catenin signaling and repressing \u03b2-amyloid production in an Alzheimer mouse model. Front Aging Neurosci 10:164. https:\/\/doi.org\/10.3389\/fnagi.2018.00164","journal-title":"Front Aging Neurosci"},{"key":"5329_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60096-7","author":"JH Voss","year":"2025","unstructured":"Voss JH, Koszegi Z, Yan Y, Shorter E, Gr\u00e4tz L, Lanner JT, Calebiro D, Schulte G (2025) WNT-induced association of Frizzled and LRP6 is not sufficient for the initiation of WNT\/\u03b2-catenin signaling. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-025-60096-7","journal-title":"Nat Commun"},{"key":"5329_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/301575","author":"W Wan","year":"2014","unstructured":"Wan W, Xia S, Kalionis B, Liu L, Li Y (2014) The role of Wnt signaling in the development of Alzheimer\u2019s disease: a potential therapeutic target? BioMed Res Int. https:\/\/doi.org\/10.1155\/2014\/301575","journal-title":"BioMed Res Int"},{"issue":"10","key":"5329_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105123","volume":"25","author":"S Lou","year":"2024","unstructured":"Lou S, Gong D, Yang M, Qiu Q, Luo J, Chen T (2024) Curcumin improves neurogenesis in Alzheimer\u2019s disease mice via the upregulation of Wnt\/\u03b2-catenin and BDNF. Int J Mol Sci 25(10):5123. https:\/\/doi.org\/10.3390\/ijms25105123","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5329_CR57","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/2211-5463.13861","volume":"14","author":"C Velez-delValle","year":"2024","unstructured":"Velez-delValle C, Hernandez-Mosqueira CP, Castro-Rodriguez LI, Vazquez-Sandoval A, Marsch-Moreno M, Kuri-Harcuch W (2024) Gene expression and characterization of clonally derived murine embryonic brown and brite adipocytes. FEBS Open Bio 14(9):1503\u20131525. https:\/\/doi.org\/10.1002\/2211-5463.13861","journal-title":"FEBS Open Bio"},{"issue":"5","key":"5329_CR58","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cmet.2019.01.005","volume":"29","author":"M Nakamura","year":"2019","unstructured":"Nakamura M, Liu T, Husain S, Zhai P, Warren JS, Hsu C-P, Matsuda T, Phiel CJ et al (2019) Glycogen synthase kinase-3\u03b1 promotes fatty acid uptake and lipotoxic cardiomyopathy. Cell Metab 29(5):1119\u20131134. https:\/\/doi.org\/10.1016\/j.cmet.2019.01.005","journal-title":"Cell Metab"},{"issue":"6","key":"5329_CR59","doi-asserted-by":"publisher","first-page":"10492","DOI":"10.3390\/cimb46090623","volume":"49","author":"L Hsing-Yi","year":"2024","unstructured":"Hsing-Yi L, Cheng-Hsiu L, Yueh-Hsiung K, Chun-Ching S (2024) Antidiabetic and antihyperlipidemic activities and molecular mechanisms of Phyllanthus emblica L. extract in mice on a high-fat diet. Current Issues in Molecular Biology 49(6):10492\u201310529. https:\/\/doi.org\/10.3390\/cimb46090623","journal-title":"Current Issues in Molecular Biology"},{"issue":"10","key":"5329_CR60","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s13238-012-2058-x","volume":"3","author":"K Gong","year":"2012","unstructured":"Gong K, Zhou F, Huang H, Gong Y, Zhang L (2012) Suppression of GSK3\u03b2 by ERK mediates lipopolysaccharide induced cell migration in macrophage through \u03b2-catenin signaling. Protein Cell 3(10):762\u2013768. https:\/\/doi.org\/10.1007\/s13238-012-2058-x","journal-title":"Protein Cell"},{"issue":"1","key":"5329_CR61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13024-016-0136-x","volume":"11","author":"RC-L Ng","year":"2016","unstructured":"Ng RC-L, Cheng O-Y, Jian M, Kwan JS-C, Ho PW-L, Cheng KK-Y, Yeung PKK, Zhou LL et al (2016) Chronic adiponectin deficiency leads to Alzheimer\u2019s disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice. Mol Neurodegener 11(1):71. https:\/\/doi.org\/10.1186\/s13024-016-0136-x","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5329_CR62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20(1):165. https:\/\/doi.org\/10.1186\/s12974-023-02853-3","journal-title":"J Neuroinflammation"},{"issue":"S13","key":"5329_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/alz.080192","volume":"19","author":"N Suhy","year":"2023","unstructured":"Suhy N, Mesentier-Louro LA, Goldman C, Forton-Juarez A, Rooklin R, Blanchard J (2023) Investigating the role of ketogenic conditions on cholesterol metabolism and neuroinflammation in APOE4 carriers. Alzheimers Dement 19(S13):e080192. https:\/\/doi.org\/10.1002\/alz.080192","journal-title":"Alzheimers Dement"},{"issue":"3","key":"5329_CR64","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/jci124853","volume":"129","author":"M Tachibana","year":"2019","unstructured":"Tachibana M, Holm M-L, Liu C-C, Shinohara M, Aikawa T, Oue H, Yamazaki Y, Martens YA et al (2019) APOE4-mediated amyloid-\u03b2 pathology depends on its neuronal receptor LRP1. J Clin Invest 129(3):1272\u20131277. https:\/\/doi.org\/10.1172\/jci124853","journal-title":"J Clin Invest"},{"key":"5329_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/4754195","volume":"2020","author":"W Yang","year":"2020","unstructured":"Yang W, Liu Y, Xu Q-Q, Xian Y-F, Lin Z-X (2020) Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K\/Akt\/GSK-3\u03b2 pathway in experimental models of Alzheimer\u2019s disease. Oxid Med Cell Longev 2020:1\u201317. https:\/\/doi.org\/10.1155\/2020\/4754195","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"5329_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.kint.2019.10.031","volume":"97","author":"T Saito","year":"2019","unstructured":"Saito T, Matsunaga A, Fukunaga M, Nagahama K, Hara S, Muso E (2019) Apolipoprotein E-related glomerular disorders. Kidney Int 97(2):279\u2013288. https:\/\/doi.org\/10.1016\/j.kint.2019.10.031","journal-title":"Kidney Int"},{"issue":"1","key":"5329_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014586","volume":"6","author":"PB Jones","year":"2011","unstructured":"Jones PB, Adams KW, Rozkalne A, Spires-Jones TL, Hshieh TT, Hashimoto T, von Armin CAF, Mielke M et al (2011) Apolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-\u03b2 in human Alzheimer brain. PLoS ONE 6(1):e14586. https:\/\/doi.org\/10.1371\/journal.pone.0014586","journal-title":"PLoS ONE"},{"issue":"5","key":"5329_CR68","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","volume":"101","author":"ME Belloy","year":"2019","unstructured":"Belloy ME, Napolioni V, Greicius MD (2019) A quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward. Neuron 101(5):820\u2013838. https:\/\/doi.org\/10.1016\/j.neuron.2019.01.056","journal-title":"Neuron"},{"issue":"17","key":"5329_CR69","doi-asserted-by":"publisher","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","volume":"256","author":"KH Weisgraber","year":"1981","unstructured":"Weisgraber KH, Rall SC Jr., Mahley RW (1981) Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 256(17):9077\u20139083","journal-title":"J Biol Chem"},{"issue":"1","key":"5329_CR70","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/bj20020207","volume":"366","author":"NM Bentley","year":"2002","unstructured":"Bentley NM, Ladu MJ, Rajan C, Getz GS, Reardon CA (2002) Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1\u201340): the role of salt bridges. Biochem J 366(1):273\u2013279. https:\/\/doi.org\/10.1042\/bj20020207","journal-title":"Biochem J"},{"issue":"2","key":"5329_CR71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen Y, Strickland MR, Soranno A, Holtzman DM (2021) Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron 109(2):205\u2013221. https:\/\/doi.org\/10.1016\/j.neuron.2020.10.008","journal-title":"Neuron"},{"issue":"6","key":"5329_CR72","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1161\/atvbaha.108.164350","volume":"28","author":"M Kockx","year":"2008","unstructured":"Kockx M, Jessup W, Kritharides L (2008) Regulation of endogenous apolipoprotein E secretion by macrophages. Arterioscler Thromb Vasc Biol 28(6):1060\u20131067. https:\/\/doi.org\/10.1161\/atvbaha.108.164350","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5329_CR73","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s13311-023-01375-3","volume":"20","author":"AC Valencia-Olvera","year":"2023","unstructured":"Valencia-Olvera AC, Balu D, Faulk N, Amiridis A, Wang Y, Pham C, Avila-Munoz E, York JM et al (2023) Inhibition of ACAT as a therapeutic target for Alzheimer\u2019s disease is independent of ApoE4 lipidation. Neurotherapeutics 20:1120\u20131137. https:\/\/doi.org\/10.1007\/s13311-023-01375-3","journal-title":"Neurotherapeutics"},{"issue":"19","key":"5329_CR74","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/jneurosci.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y (2006) Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci 26(19):4985\u20134994. https:\/\/doi.org\/10.1523\/jneurosci.5476-05.2006","journal-title":"J Neurosci"},{"issue":"39","key":"5329_CR75","doi-asserted-by":"publisher","first-page":"40987","DOI":"10.1074\/jbc.m407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, Holtzman DM (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 279(39):40987\u201340993. https:\/\/doi.org\/10.1074\/jbc.m407963200","journal-title":"J Biol Chem"},{"issue":"6","key":"5329_CR76","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","volume":"60","author":"FW Pfrieger","year":"2003","unstructured":"Pfrieger FW (2003) Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci 60(6):1158\u20131171. https:\/\/doi.org\/10.1007\/s00018-003-3018-7","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"5329_CR77","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/s0006-8993(01)03228-0","volume":"924","author":"CM Lauderback","year":"2002","unstructured":"Lauderback CM, Kanski J, Hackett JM, Maeda N, Kindy MS, Butterfield DA (2002) Apolipoprotein E modulates Alzheimer\u2019s Abeta(1\u201342)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Res 924(1):90\u201397. https:\/\/doi.org\/10.1016\/s0006-8993(01)03228-0","journal-title":"Brain Res"},{"issue":"1","key":"5329_CR78","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/s1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 20(1):68\u201380. https:\/\/doi.org\/10.1016\/s1474-4422(20)30412-9","journal-title":"Lancet Neurol"},{"key":"5329_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00577-1","author":"N Wang","year":"2022","unstructured":"Wang N, Wang M, Jeevaratnam S, Rosenberg C, Ikezu TC, Shue F, Doss SV, Alnobani A et al (2022) Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-022-00577-1","journal-title":"Mol Neurodegener"},{"issue":"11","key":"5329_CR80","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","volume":"24","author":"C-C Liu","year":"2023","unstructured":"Liu C-C, Wang N, Chen Y, Inoue Y, Shue F, Ren Y, Wang M, Qiao W et al (2023) Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer\u2019s disease. Nat Immunol 24(11):1854\u20131866. https:\/\/doi.org\/10.1038\/s41590-023-01640-9","journal-title":"Nat Immunol"},{"key":"5329_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153687","volume":"92","author":"X-N Xu","year":"2021","unstructured":"Xu X-N, Jiang Y, Yan L-Y, Yin S-Y, Wang Y-H, Wang S-B, Fang L-H, Du G-H (2021) Aesculin suppresses the NLRP3 inflammasome-mediated pyroptosis via the Akt\/GSK3\u03b2\/NF-\u03baB pathway to mitigate myocardial ischemia\/reperfusion injury. Phytomedicine 92:153687. https:\/\/doi.org\/10.1016\/j.phymed.2021.153687","journal-title":"Phytomedicine"},{"issue":"s2","key":"5329_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/alz.041052","volume":"16","author":"CM Kloske","year":"2020","unstructured":"Kloske CM, Dugan A, Woolums AE, Lee T, Anderson S, Patel E, Abner EL, Nelson PT et al (2020) Impaired neuroinflammatory response of ApoE4 in Alzheimer\u2019s disease patients. Alzheimers Dement 16(s2):e041052. https:\/\/doi.org\/10.1002\/alz.041052","journal-title":"Alzheimers Dement"},{"issue":"1","key":"5329_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101594","volume":"59","author":"S Parhizkar","year":"2022","unstructured":"Parhizkar S, Holtzman DM (2022) APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease. Semin Immunol 59(1):101594. https:\/\/doi.org\/10.1016\/j.smim.2022.101594","journal-title":"Semin Immunol"},{"issue":"37","key":"5329_CR84","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2516103122","volume":"122","author":"AP Verduzco Espinoza","year":"2025","unstructured":"Verduzco Espinoza AP, Na N, Campanati L, Ngo P, Baldwin KK, Cline HT (2025) Microglia-to-neuron signaling links APOE4 and inflammation to enhanced neuronal lipid metabolism and network activity. Proc Natl Acad Sci U S A 122(37):e2516103122. https:\/\/doi.org\/10.1073\/pnas.2516103122","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"5329_CR85","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.stemcr.2021.07.017","volume":"16","author":"S-I Lee","year":"2021","unstructured":"Lee S-I, Jeong W, Lim H, Cho S, Lee H, Jang Y, Cho J, Bae S et al (2021) APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and A\u03b2 generation. Stem Cell Reports 16(9):2128\u20132137. https:\/\/doi.org\/10.1016\/j.stemcr.2021.07.017","journal-title":"Stem Cell Reports"},{"key":"5329_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00563-y","author":"T Liang","year":"2021","unstructured":"Liang T, Hang W, Chen J, Wu Y, Wen B, Xu K, Ding B, Chen J (2021) ApoE4 (\u0394272\u2013299) induces mitochondrial-associated membrane formation and mitochondrial impairment by enhancing GRP75-modulated mitochondrial calcium overload in neuron. Cell Biosci. https:\/\/doi.org\/10.1186\/s13578-021-00563-y","journal-title":"Cell Biosci"},{"issue":"11","key":"5329_CR87","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jamaneurol.2018.3139","volume":"75","author":"AM Wennberg","year":"2018","unstructured":"Wennberg AM, Tosakulwong N, Lesnick TG, Murray ME, Whitwell JL, Liesinger AM, Petrucelli L, Boeve BF et al (2018) Association of apolipoprotein E \u03b54 with transactive response DNA-binding protein 43. JAMA Neurol 75(11):1347\u20131354. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3139","journal-title":"JAMA Neurol"},{"key":"5329_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00503-x","author":"A Meneses","year":"2021","unstructured":"Meneses A, Koga S, O\u2019Leary J, Dickson DW, Bu G, Zhao N (2021) TDP-43 pathology in Alzheimer\u2019s disease. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-021-00503-x","journal-title":"Mol Neurodegener"},{"issue":"9","key":"5329_CR89","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/s1474-4422(18)30251-5","volume":"17","author":"H-S Yang","year":"2018","unstructured":"Yang H-S, Yu L, White CC, Chibnik LB, Chhatwal JP, Sperling RA, Bennett DA, Schneider JA et al (2018) Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study. Lancet Neurol 17(9):773\u2013781. https:\/\/doi.org\/10.1016\/s1474-4422(18)30251-5","journal-title":"Lancet Neurol"},{"issue":"7s","key":"5329_CR90","doi-asserted-by":"publisher","first-page":"P1533","DOI":"10.1016\/j.jalz.2018.07.057","volume":"14","author":"AMV Wennberg","year":"2006","unstructured":"Wennberg AMV, Lesnick TG, Tosakulwong N, Murray ME, Whitwell JL, Liesinger AM, Petrucelli L, Boeve BF et al (2006) Structural equation modelling reveals a direct and indirect effect of Apoe \u03b54 on tar dna binding protein 43. Alzheimers Dement 14(7s):P1533. https:\/\/doi.org\/10.1016\/j.jalz.2018.07.057","journal-title":"Alzheimers Dement"},{"issue":"3","key":"5329_CR91","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"Y-WA Huang","year":"2017","unstructured":"Huang Y-WA, Zhou B, Wernig M, S\u00fcdhof TC (2017) ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion. Cell 168(3):427\u2013441. https:\/\/doi.org\/10.1016\/j.cell.2016.12.044","journal-title":"Cell"},{"issue":"7","key":"5329_CR92","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276\u20131290. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"issue":"S1","key":"5329_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/alz.093337","volume":"20","author":"NS Leibold","year":"2025","unstructured":"Leibold NS, Viswanathan VG, Radulescu L, Kotiya D, Verma N, Despa F (2025) Altering ApoE in mice expressing human amylin in the pancreas exacerbates brain amyloid pathology and behavior deficits. Alzheimers Dement 20(S1):e093337. https:\/\/doi.org\/10.1002\/alz.093337","journal-title":"Alzheimers Dement"},{"issue":"4","key":"5329_CR94","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"GW Rebeck","year":"1993","unstructured":"Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer\u2019s disease: allelic variation and receptor interactions. Neuron 11(4):575\u2013580. https:\/\/doi.org\/10.1016\/0896-6273(93)90070-8","journal-title":"Neuron"},{"issue":"10","key":"5329_CR95","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1042\/bcj20180068","volume":"475","author":"I Dafnis","year":"2018","unstructured":"Dafnis I, Raftopoulou C, Mountaki C, Megalou E, Zannis VI, Chroni A (2018) ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and A\u03b2 production independently of their cholesterol efflux capacity. Biochem J 475(10):1839\u20131859. https:\/\/doi.org\/10.1042\/bcj20180068","journal-title":"Biochem J"},{"issue":"5","key":"5329_CR96","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.neuron.2009.11.013","volume":"64","author":"J Kim","year":"2009","unstructured":"Kim J, Castellano JM, Jiang H, Basak JM, Parsadanian M, Pham V, Mason SM, Paul SM et al (2009) Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance. Neuron 64(5):632\u2013644. https:\/\/doi.org\/10.1016\/j.neuron.2009.11.013","journal-title":"Neuron"},{"issue":"1","key":"5329_CR97","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-024-00716-w","volume":"13","author":"Q Ma","year":"2024","unstructured":"Ma Q, Zhao Z, Sagare AP, Wu Y, Wang M, Owens NC, Verghese PB, Herz J et al (2024) Blood\u2013brain barrier-associated pericytes internalize and clear aggregated amyloid-\u03b242 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener 13(1):57. https:\/\/doi.org\/10.1186\/s13024-024-00716-w","journal-title":"Mol Neurodegener"},{"issue":"21","key":"5329_CR98","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1093\/emboj\/cdf568","volume":"21","author":"CU Pietrzik","year":"2002","unstructured":"Pietrzik CU, Busse T, Merriam DE, Weggen S, Koo EH (2002) The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J 21(21):5691\u20135700. https:\/\/doi.org\/10.1093\/emboj\/cdf568","journal-title":"EMBO J"},{"issue":"6","key":"5329_CR99","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/jnc.15750","volume":"164","author":"Y Sun","year":"2022","unstructured":"Sun Y, Islam S, Gao Y, Nakamura T, Zou K, Michikawa M (2022) Apolipoprotein E4 inhibits \u03b3-secretase activity via binding to the \u03b3-secretase complex. J Neurochem 164(6):858\u2013874. https:\/\/doi.org\/10.1111\/jnc.15750","journal-title":"J Neurochem"},{"issue":"2","key":"5329_CR100","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ana.24369","volume":"23","author":"A Serrano-Pozo","year":"2015","unstructured":"Serrano-Pozo A, Qian J, Monsell SE, Betensky RA, Hyman BT (2015) APOE\u03b52 is associated with milder clinical and pathological Alzheimer disease. Ann Neurol 23(2):112\u2013112. https:\/\/doi.org\/10.1002\/ana.24369","journal-title":"Ann Neurol"},{"issue":"53","key":"5329_CR101","doi-asserted-by":"publisher","first-page":"44593","DOI":"10.1074\/jbc.m112.420224","volume":"287","author":"J Li","year":"2012","unstructured":"Li J, Kanekiyo T, Shinohara M, Zhang Y, LaDu MJ, Xu H, Bu G (2012) Differential regulation of amyloid-beta endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms. J Biol Chem 287(53):44593\u201344601. https:\/\/doi.org\/10.1074\/jbc.m112.420224","journal-title":"J Biol Chem"},{"issue":"43","key":"5329_CR102","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/jneurosci.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO, Mitani A, Joyner D et al (2012) Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide. J Neurosci 32(43):15181\u201315192. https:\/\/doi.org\/10.1523\/jneurosci.1542-12.2012","journal-title":"J Neurosci"},{"issue":"34","key":"5329_CR103","doi-asserted-by":"publisher","first-page":"13247","DOI":"10.1074\/jbc.ra117.001388","volume":"293","author":"E Kara","year":"2018","unstructured":"Kara E, Marks JD, Roe AD, Commins C, Fan Z, Calvo-Rodriguez M, Wegmann S, Hudry E et al (2018) A flow cytometry-based in vitro assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type. J Biol Chem 293(34):13247\u201313256. https:\/\/doi.org\/10.1074\/jbc.ra117.001388","journal-title":"J Biol Chem"},{"issue":"1","key":"5329_CR104","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-pathmechdis-030421-112756","volume":"17","author":"N Koutsodendris","year":"2022","unstructured":"Koutsodendris N, Nelson MR, Rao A, Huang Y (2022) Apolipoprotein E and Alzheimer\u2019s disease: findings, hypotheses, and potential mechanisms. Annu Rev Pathol Mech Dis 17(1):73\u201399. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-030421-112756","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"5329_CR105","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neurobiolaging.2021.10.015","volume":"110","author":"MJ Novy","year":"2022","unstructured":"Novy MJ, Newbury SF, Liemisa B, Morales-Corraliza J, Alldred MJ, Ginsberg SD, Mathews PM (2022) Expression and proteolytic processing of the amyloid precursor protein is unaffected by the expression of the three human apolipoprotein E alleles in the brains of mice. Neurobiol Aging 110:73\u201376. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.10.015","journal-title":"Neurobiol Aging"},{"key":"5329_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00556-6","author":"G Bu","year":"2022","unstructured":"Bu G (2022) APOE targeting strategy in Alzheimer\u2019s disease: lessons learned from protective variants. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-022-00556-6","journal-title":"Mol Neurodegener"},{"key":"5329_CR107","doi-asserted-by":"publisher","unstructured":"Mattsson-Carlgren N, Andersson E, Janelidze S, Ossenkoppele R, Insel P, Strandberg O, Zetterberg H, Rosen HJ et al (2020) A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer\u2019s disease. Sci Adv 6(16). https:\/\/doi.org\/10.1126\/sciadv.aaz2387","DOI":"10.1126\/sciadv.aaz2387"},{"key":"5329_CR108","doi-asserted-by":"publisher","unstructured":"Neitzel J, Franzmeier N, Rubinski A, Binette AP, Poirier J, Villeneuve S, Ewers M, null n (2020) ApoE4 associated with higher tau accumulation independent of amyloid burden. Alzheimer's & Dementia 16(S2). https:\/\/doi.org\/10.1002\/alz.046206","DOI":"10.1002\/alz.046206"},{"issue":"15","key":"5329_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113889","volume":"226","author":"L Qu","year":"2021","unstructured":"Qu L, Li S, Ji L, Luo S, Ding M, Yin F, Wang C, Luo H et al (2021) Discovery of PT-65 as a highly potent and selective proteolysis-targeting chimera degrader of GSK3 for treating Alzheimer\u2019s disease. Eur J Med Chem 226(15):113889. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113889","journal-title":"Eur J Med Chem"},{"issue":"9","key":"5329_CR110","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/ijbs.57078","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H, Cao Y, Li H (2021) Interaction between A\u03b2 and tau in the pathogenesis of Alzheimer\u2019s disease. Int J Biol Sci 17(9):2181\u20132192. https:\/\/doi.org\/10.7150\/ijbs.57078","journal-title":"Int J Biol Sci"},{"issue":"8","key":"5329_CR111","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70536","volume":"31","author":"J Ding","year":"2025","unstructured":"Ding J, Sun B, Gao Y, Gu C, Zhang J, Wang L, Zheng J, Xia B et al (2025) APOE4 exacerbates cerebral tau pathology through cholesterol-induced degradation of phosphatase in atherosclerosis. CNS Neurosci Ther 31(8):e70536. https:\/\/doi.org\/10.1111\/cns.70536","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"5329_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115961","volume":"44","author":"RA Stephenson","year":"2025","unstructured":"Stephenson RA, Sepulveda J, Johnson KR, Lita A, Gopalakrishnan J, Acri DJ, Beilina A, Cheng L et al (2025) Triglyceride metabolism controls inflammation and microglial phenotypes associated with APOE4. Cell Rep 44(7):115961. https:\/\/doi.org\/10.1016\/j.celrep.2025.115961","journal-title":"Cell Rep"},{"issue":"3","key":"5329_CR113","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.celrep.2017.12.066","volume":"22","author":"BA Friedman","year":"2018","unstructured":"Friedman BA, Srinivasan K, Ayalon G, Meilandt WJ, Lin H, Huntley MA, Cao Y, Lee S-H et al (2018) Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer\u2019s disease not evident in mouse models. Cell Rep 22(3):832\u2013847. https:\/\/doi.org\/10.1016\/j.celrep.2017.12.066","journal-title":"Cell Rep"},{"key":"5329_CR114","doi-asserted-by":"publisher","DOI":"10.1126\/science.357.6347.160-c","author":"SM Hurtley","year":"2017","unstructured":"Hurtley SM (2017) A microglia type associated with AD. Science. https:\/\/doi.org\/10.1126\/science.357.6347.160-c","journal-title":"Science"},{"issue":"11","key":"5329_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-11-111","volume":"19","author":"GA Rodriguez","year":"2014","unstructured":"Rodriguez GA, Tai LM, LaDu MJ, Rebeck GW (2014) Human APOE4 increases microglia reactivity at A\u03b2 plaques in a mouse model of A\u03b2 deposition. J Neuroinflammation 19(11):1\u201311. https:\/\/doi.org\/10.1186\/1742-2094-11-111","journal-title":"J Neuroinflammation"},{"issue":"6","key":"5329_CR116","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/glia.23571","volume":"67","author":"Qq Yang","year":"2018","unstructured":"Yang Qq, Zhou Jw (2018) Neuroinflammation in the central nervous system: symphony of glial cells. Glia 67(6):1017\u20131035. https:\/\/doi.org\/10.1002\/glia.23571","journal-title":"Glia"},{"issue":"2","key":"5329_CR117","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld J, Yip O, Kim MJ, Huang Y (2024) Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci 25(2):91\u2013110. https:\/\/doi.org\/10.1038\/s41583-023-00776-9","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"5329_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103238","volume":"24","author":"VA Moser","year":"2021","unstructured":"Moser VA, Workman MJ, Hurwitz SJ, Lipman RM, Pike CJ, Svendsen CN (2021) Microglial transcription profiles in mouse and human are driven by APOE4 and sex. iScience 24(11):103238. https:\/\/doi.org\/10.1016\/j.isci.2021.103238","journal-title":"iScience"},{"issue":"11","key":"5329_CR119","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.immuni.2024.09.014","volume":"57","author":"K Seiji","year":"2024","unstructured":"Seiji K, Stefan AB, Lena S, Lennart S, Andrew OS, Simona V, Luca B, Shreeya K et al (2024) Apolipoprotein E aggregation in microglia initiates Alzheimer\u2019s disease pathology by seeding \u03b2-amyloidosis. Immunity 57(11):2651\u20132668. https:\/\/doi.org\/10.1016\/j.immuni.2024.09.014","journal-title":"Immunity"},{"issue":"1","key":"5329_CR120","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.stem.2024.10.005","volume":"32","author":"R Antara","year":"2024","unstructured":"Antara R, Nuo C, Min Joo K, Jessica B, Oscar Y, Zherui L, David S, Yanxia H et al (2024) Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer\u2019s disease model. Cell Stem Cell 32(1):86\u2013104. https:\/\/doi.org\/10.1016\/j.stem.2024.10.005","journal-title":"Cell Stem Cell"},{"issue":"22","key":"5329_CR121","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt H, Frost EL, Shapiro DA, Holliday C, Zengeler KE, Voithofer G, Bolte AC, Lammert CR, Kulas JA, Ulland TK, Lukens JR (2022) SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell 185(22):4153\u20134169. https:\/\/doi.org\/10.1016\/j.cell.2022.09.030","journal-title":"Cell"},{"key":"5329_CR122","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1007\/s12035-022-02923-2","volume":"59","author":"MH Yousef","year":"2022","unstructured":"Yousef MH, Salama M, El-Fawal HAN, Abdelnaser A (2022) Selective GSK3\u03b2 inhibition mediates an Nrf2-independent anti-inflammatory microglial response. Mol Neurobiol 59:5591\u20135611. https:\/\/doi.org\/10.1007\/s12035-022-02923-2","journal-title":"Mol Neurobiol"},{"issue":"4","key":"5329_CR123","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/ptr.8264","volume":"39","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang H, Liu Z, Huang T, Yi R, Ma Z, Gao Y (2024) Salidroside improves blood\u2013brain barrier integrity and cognitive function in hypobaric hypoxia mice by inhibiting microglia activation through GSK3\u03b2. Phytother Res 39(4):1808\u20131825. https:\/\/doi.org\/10.1002\/ptr.8264","journal-title":"Phytother Res"},{"key":"5329_CR124","doi-asserted-by":"publisher","first-page":"7026","DOI":"10.1007\/s12035-024-04034-6","volume":"61","author":"J Zhang","year":"2024","unstructured":"Zhang J, Gu Y, Sun W, Yu L, Li T (2024) Tetrahydrocurcumin protects against GSK3\u03b2\/PTEN\/PI3K\/Akt-mediated neuroinflammatory responses and microglial polarization following traumatic brain injury. Mol Neurobiol 61:7026\u20137036. https:\/\/doi.org\/10.1007\/s12035-024-04034-6","journal-title":"Mol Neurobiol"},{"key":"5329_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09335-x","author":"A Liviu","year":"2025","unstructured":"Liviu A, Zhen Kai N, Chenxi Q, Jaejoon C, Marianna L, Derek MD, Sara EH, Ella KL et al (2025) Lithium deficiency and the onset of Alzheimer\u2019s disease. Nature. https:\/\/doi.org\/10.1038\/s41586-025-09335-x","journal-title":"Nature"},{"issue":"10","key":"5329_CR126","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/s41418-022-00997-y","volume":"29","author":"S Arumugam","year":"2022","unstructured":"Arumugam S, Qin Y, Liang Z, Han S-N, Boodapati SLT, Li J, Lu Q, Flavell RA et al (2022) GSK3\u03b2 mediates the spatiotemporal dynamics of NLRP3 inflammasome activation. Cell Death Differ 29(10):2060\u20132069. https:\/\/doi.org\/10.1038\/s41418-022-00997-y","journal-title":"Cell Death Differ"},{"issue":"2","key":"5329_CR127","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cellsig.2008.10.014","volume":"21","author":"CJ Yuskaitis","year":"2008","unstructured":"Yuskaitis CJ, Jope RS (2008) Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal 21(2):264\u2013273. https:\/\/doi.org\/10.1016\/j.cellsig.2008.10.014","journal-title":"Cell Signal"},{"issue":"15","key":"5329_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158263","volume":"25","author":"F K\u00fchl","year":"2024","unstructured":"K\u00fchl F, Brand K, Lichtinghagen R, Huber R (2024) GSK3-driven modulation of inflammation and tissue integrity in the animal model. Int J Mol Sci 25(15):8263. https:\/\/doi.org\/10.3390\/ijms25158263","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5329_CR129","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, Pluvinage JV, Mathur V et al (2020) Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci 23(2):194\u2013208. https:\/\/doi.org\/10.1038\/s41593-019-0566-1","journal-title":"Nat Neurosci"},{"issue":"13","key":"5329_CR130","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","volume":"185","author":"J Tcw","year":"2022","unstructured":"Tcw J, Qian L, Pipalia NH, Chao MJ, Liang SA, Shi Y, Jain BR, Bertelsen SE et al (2022) Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell 185(13):2213\u20132233. https:\/\/doi.org\/10.1016\/j.cell.2022.05.017","journal-title":"Cell"},{"issue":"11","key":"5329_CR131","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","volume":"24","author":"Z Yin","year":"2023","unstructured":"Yin Z, Rosenzweig N, Kleemann KL, Zhang X, Brand\u00e3o W, Margeta MA, Schroeder C, Sivanathan KN et al (2023) APOE4 impairs the microglial response in Alzheimer\u2019s disease by inducing TGF\u03b2-mediated checkpoints. Nat Immunol 24(11):1839\u20131853. https:\/\/doi.org\/10.1038\/s41590-023-01627-6","journal-title":"Nat Immunol"},{"issue":"8","key":"5329_CR132","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","volume":"29","author":"MB Victor","year":"2022","unstructured":"Victor MB, Leary N, Luna X, Meharena HS, Scannail AN, Bozzelli PL, Samaan G, Murdock MH et al (2022) Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity. Cell Stem Cell 29(8):1197\u20131212. https:\/\/doi.org\/10.1016\/j.stem.2022.07.005","journal-title":"Cell Stem Cell"},{"issue":"2","key":"5329_CR133","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1515\/hsz-2018-0284","volume":"400","author":"Y Horiuchi","year":"2019","unstructured":"Horiuchi Y, Ohkawa R, Lai S-J, Yamazaki A, Ikoma H, Yano K, Kameda T, Tozuka M (2019) Characterization of the cholesterol efflux of apolipoprotein E-containing high-density lipoprotein in THP-1 cells. Biol Chem 400(2):209\u2013218. https:\/\/doi.org\/10.1515\/hsz-2018-0284","journal-title":"Biol Chem"},{"key":"5329_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-60","author":"C Marquer","year":"2014","unstructured":"Marquer C, Laine J, Dauphinot L, Hanbouch L, Lemercier-Neuillet C, Pierrot N, Bossers K, Le M et al (2014) Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer\u2019s disease early phenotypes. Mol Neurodegener. https:\/\/doi.org\/10.1186\/1750-1326-9-60","journal-title":"Mol Neurodegener"},{"issue":"7","key":"5329_CR135","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/atvbaha.116.307023","volume":"36","author":"RW Mahley","year":"2016","unstructured":"Mahley RW (2016) Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism. Arterioscler Thromb Vasc Biol 36(7):1305\u20131315. https:\/\/doi.org\/10.1161\/atvbaha.116.307023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"5329_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101728","volume":"81","author":"G D\u00edaz","year":"2022","unstructured":"D\u00edaz G, Lengele L, Sourdet S, Soriano G, de Souto BP (2022) Nutrients and amyloid \u03b2 status in the brain: a narrative review. Ageing Res Rev 81(1):101728. https:\/\/doi.org\/10.1016\/j.arr.2022.101728","journal-title":"Ageing Res Rev"},{"key":"5329_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092452","author":"A Sarchione","year":"2021","unstructured":"Sarchione A, Marchand A, Taymans J-M, Chartier-Harlin M-C (2021) Alpha-synuclein and lipids: the elephant in the room? Cells. https:\/\/doi.org\/10.3390\/cells10092452","journal-title":"Cells"},{"issue":"3","key":"5329_CR138","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00401-023-02601-0","volume":"146","author":"M Flores-Leon","year":"2023","unstructured":"Flores-Leon M, Outeiro TF (2023) More than meets the eye in Parkinson\u2019s disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathol 146(3):369\u2013385. https:\/\/doi.org\/10.1007\/s00401-023-02601-0","journal-title":"Acta Neuropathol"},{"issue":"12","key":"5329_CR139","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3390\/antiox10121991","volume":"10","author":"J Mett","year":"2021","unstructured":"Mett J (2021) The impact of medium chain and polyunsaturated \u03c9-3-fatty acids on amyloid-\u03b2 deposition, oxidative stress and metabolic dysfunction associated with Alzheimer\u2019s disease. Antioxidants 10(12):1991. https:\/\/doi.org\/10.3390\/antiox10121991","journal-title":"Antioxidants"},{"issue":"1","key":"5329_CR140","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3389\/fnins.2022.842814","volume":"16","author":"M Wu","year":"2022","unstructured":"Wu M, Zhai Y, Liang X, Chen W, Lin R, Ma L, Huang Y, Zhao D et al (2022) Connecting the dots between hypercholesterolemia and Alzheimer\u2019s disease: a potential mechanism based on 27-hydroxycholesterol. Front Neurosci 16(1):814\u2013842. https:\/\/doi.org\/10.3389\/fnins.2022.842814","journal-title":"Front Neurosci"},{"issue":"1","key":"5329_CR141","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-023-00343-3","volume":"12","author":"C de Dios","year":"2023","unstructured":"de Dios C, Abadin X, Roca-Agujetas V, Jimenez-Martinez M, Morales A, Trullas R, Mari M, Colell A (2023) Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis. Transl Neurodegener 12(1):10. https:\/\/doi.org\/10.1186\/s40035-023-00343-3","journal-title":"Transl Neurodegener"},{"issue":"21","key":"5329_CR142","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1146\/annurev-biochem-032620-104801","volume":"91","author":"A-C Raulin","year":"2022","unstructured":"Raulin A-C, Martens YA, Bu G (2022) Lipoproteins in the central nervous system: from biology to pathobiology. Annu Rev Biochem 91(21):731\u2013759. https:\/\/doi.org\/10.1146\/annurev-biochem-032620-104801","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"5329_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.640956","volume":"12","author":"AS G\u00e1lvez","year":"2021","unstructured":"G\u00e1lvez AS, Ram\u00edrez H, Placencia P, Rojas C, Urz\u00faa X, Kalergis AM, Salazar LA, Escobar-Vera J (2021) Single nucleotide polymorphisms in apolipoprotein B, apolipoprotein E, and methylenetetrahydrofolate reductase are associated with serum lipid levels in northern chilean subjects. A pilot study. Frontiers in Genetics 12(1):640956. https:\/\/doi.org\/10.3389\/fgene.2021.640956","journal-title":"Frontiers in Genetics"},{"issue":"8","key":"5329_CR144","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","volume":"31","author":"DM Hatters","year":"2006","unstructured":"Hatters DM, Peters-Libeu CA, Weisgraber KH (2006) Apolipoprotein E structure: insights into function. Trends Biochem Sci 31(8):445\u2013454. https:\/\/doi.org\/10.1016\/j.tibs.2006.06.008","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"5329_CR145","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","volume":"96","author":"N Zhao","year":"2017","unstructured":"Zhao N, Liu C-C, Van Ingelgom AJ, Martens YA, Linares C, Knight JA, Painter MM, Sullivan PM et al (2017) Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron 96(1):115\u2013129. https:\/\/doi.org\/10.1016\/j.neuron.2017.09.003","journal-title":"Neuron"},{"issue":"5","key":"5329_CR146","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1046\/j.1471-4159.2003.02088.x","volume":"87","author":"A Cedazo-M\u00ednguez","year":"2003","unstructured":"Cedazo-M\u00ednguez A, Popescu BO, Blanco-Mill\u00e1n JM, Akterin S, Pei JJ, Winblad B, Cowburn RF (2003) Apolipoprotein E and beta-amyloid (1\u201342) regulation of glycogen synthase kinase-3beta. J Neurochem 87(5):1152\u20131164. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02088.x","journal-title":"J Neurochem"},{"issue":"2","key":"5329_CR147","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1096\/fj.02-0434fje","volume":"17","author":"N Ohkubo","year":"2002","unstructured":"Ohkubo N, Lee YD, Morishima A, Terashima T, Kikkawa S, Tohyama M, Sakanaka M, Tanaka J et al (2002) Apolipoprotein E and reelin ligands modulate tau phosphorylation through an Apolipoprotein E receptor\/diables-1\/glycogen synthase kinase-3beta cascade. FASEB J 17(2):295\u2013297. https:\/\/doi.org\/10.1096\/fj.02-0434fje","journal-title":"FASEB J"},{"issue":"12","key":"5329_CR148","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1177\/1535370215589908","volume":"240","author":"B Cui","year":"2015","unstructured":"Cui B, Jin J, Ding X, Deng M, Yu S, Song M, Yu Y, Zhao X et al (2015) Glycogen synthase kinase 3\u03b2 inhibition enhanced proliferation, migration and functional re-endothelialization of endothelial progenitor cells in hypercholesterolemia microenvironment. Exp Biol Med (Maywood) 240(12):1752\u20131763. https:\/\/doi.org\/10.1177\/1535370215589908","journal-title":"Exp Biol Med (Maywood)"},{"issue":"18","key":"5329_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810228","volume":"25","author":"D Toral-Rios","year":"2024","unstructured":"Toral-Rios D, Pichardo-Rojas P, Ruiz-S\u00e1nchez E, Rosas-Carrasco \u00d3, Carvajal-Garc\u00eda R, G\u00e1lvez-Couti\u00f1o DC, Mart\u00ednez-Rodr\u00edguez NL, Rubio-Ch\u00e1vez AD et al (2024) Synergistic effect between the APOE \u03b54 allele with genetic variants of GSK3B and MAPT: differential profile between refractory epilepsy and Alzheimer disease. Int J Mol Sci 25(18):10228. https:\/\/doi.org\/10.3390\/ijms251810228","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5329_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/cells14040243","volume":"14","author":"D Dias","year":"2025","unstructured":"Dias D, Portugal CC, Relvas J, Socodato R (2025) From genetics to neuroinflammation: the impact of ApoE4 on microglial function in Alzheimer\u2019s disease. Cells 14(4):243. https:\/\/doi.org\/10.3390\/cells14040243","journal-title":"Cells"},{"issue":"5","key":"5329_CR151","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.neuron.2024.12.016","volume":"113","author":"L Emmy","year":"2025","unstructured":"Emmy L, Camila B, Steven CB, Mark K, Indigo VLR, Delsy M, Nina D, Olivia MT et al (2025) CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactions. Neuron 113(5):701\u2013718. https:\/\/doi.org\/10.1016\/j.neuron.2024.12.016","journal-title":"Neuron"},{"issue":"5","key":"5329_CR152","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.25455","volume":"85","author":"AR Wadhwani","year":"2019","unstructured":"Wadhwani AR, Affaneh A, Van Gulden S, Kessler JA (2019) Neuronal apolipoprotein E4 increases cell death and p-tau release in Alzheimer\u2019s disease. Ann Neurol 85(5):726\u2013739. https:\/\/doi.org\/10.1002\/ana.25455","journal-title":"Ann Neurol"},{"key":"5329_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911610","author":"L Song","year":"2022","unstructured":"Song L, Oseid DE, Wells EA, Robinson AS (2022) The interplay between GSK3\u03b2 and tau Ser262 phosphorylation during the progression of tau pathology. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231911610","journal-title":"Int J Mol Sci"},{"key":"5329_CR154","doi-asserted-by":"publisher","unstructured":"Chakraborty P, Ib\u00e1\u00f1ez de Opakua A, Purslow JA, Fromm SA, Chatterjee D, Zachrdla M, Zhuang S, Puri S, Wolozin B, Zweckstetter M (2024) GSK3\u03b2 phosphorylation catalyzes the aggregation of tau into Alzheimer\u2019s disease-like filaments. Proc Natl Acad Sci USA 121(52). https:\/\/doi.org\/10.1073\/pnas.2414176121","DOI":"10.1073\/pnas.2414176121"},{"key":"5329_CR155","doi-asserted-by":"publisher","DOI":"10.1002\/alz.094043","author":"A Steward","year":"2025","unstructured":"Steward A, Biel D, Roemer SN, Zhu Z, Pescoller J, Wagner F, Gross M, Dichgans M et al (2025) The role of ApoE4 in the acceleration of tau aggregation. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.094043","journal-title":"Alzheimers Dement"},{"key":"5329_CR156","doi-asserted-by":"publisher","unstructured":"Dincer A, Gordon BA, Keefe SJ, Flores SE, Schultz SA, Paulick AM, Feldman RL, Shady KE, Hornbeck RC, Zhou Y, Morris JC, Benzinger TLS (2020) APOE4 status influences the amyloid and tau relationship. Alzheimers Dement 16(55). https:\/\/doi.org\/10.1002\/alz.042093","DOI":"10.1002\/alz.042093"},{"key":"5329_CR157","doi-asserted-by":"publisher","unstructured":"Cicognola C, Salvad\u00f3 G, Smith R, Palmqvist S, Stomrud E, Betthauser T, Johnson S, Janelidze S et al (2025) APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-\u03b2. Brain 16(1). https:\/\/doi.org\/10.1093\/brain\/awaf016","DOI":"10.1093\/brain\/awaf016"},{"issue":"12","key":"5329_CR158","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamaneurol.2023.4038","volume":"80","author":"A Steward","year":"2023","unstructured":"Steward A, Biel D, Dewenter A, Roemer S, Wagner F, Dehsarvi A, Rathore S, Otero Svaldi D et al (2023) ApoE4 and connectivity-mediated spreading of tau pathology at lower amyloid levels. JAMA Neurol 80(12):1295\u20131306. https:\/\/doi.org\/10.1001\/jamaneurol.2023.4038","journal-title":"JAMA Neurol"},{"issue":"22","key":"5329_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223616","volume":"11","author":"A-N Lazar","year":"2022","unstructured":"Lazar A-N, Hanbouch L, Boussicaut L, Fourmaux B, Daira P, Millan MJ, Bernoud-Hubac N, Potier M-C (2022) Lipid dys-homeostasis contributes to APOE4-associated AD pathology. Cells 11(22):3616. https:\/\/doi.org\/10.3390\/cells11223616","journal-title":"Cells"},{"key":"5329_CR160","doi-asserted-by":"publisher","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, Gallardo G, Wang K, Roh J, Robinson G, Finn MB, Jiang H, Sullivan PM, Baufeld C, Wood MW, Sutphen C, McCue L, Xiong C, Del-Aguila JL, Morris JC, Cruchaga C, Fagan AM, Miller BL, Boxer AL, Seeley WW, Butovsky O, Barres BA, Paul SM, Holtzman DM (2017) ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549:523\u2013527. https:\/\/doi.org\/10.1038\/nature24016","DOI":"10.1038\/nature24016"},{"issue":"4","key":"5329_CR161","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.3892\/mmr.2019.10571","volume":"20","author":"Y Ding","year":"2019","unstructured":"Ding Y, Kang A, Tang Q, Zhao Y (2019) Inhibition of HDAC6 expression decreases brain injury induced by APOE4 and A\u03b2 co-aggregation in rats. Mol Med Rep 20(4):3363\u20133370. https:\/\/doi.org\/10.3892\/mmr.2019.10571","journal-title":"Mol Med Rep"},{"issue":"1","key":"5329_CR162","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/jad-2012-120973","volume":"33","author":"M-C Badia","year":"2012","unstructured":"Badia M-C, Lloret A, Giraldo E, Das\u00ed F, Olaso G, Alonso M-D, Vi\u00f1a J (2012) Lymphocytes from young healthy persons carrying the ApoE4 allele overexpress stress-related proteins involved in the pathophysiology of Alzheimer\u2019s disease. J Alzheimers Dis 33(1):77\u201383. https:\/\/doi.org\/10.3233\/jad-2012-120973","journal-title":"J Alzheimers Dis"},{"key":"5329_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11654-7","author":"J Cao","year":"2017","unstructured":"Cao J, Gaamouch FE, Meabon JS, Meeker KD, Zhu L, Zhong MB, Bendik J, Elder G et al (2017) ApoE4-associated phospholipid dysregulation contributes to development of tau hyper-phosphorylation after traumatic brain injury. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-11654-7","journal-title":"Sci Rep"},{"key":"5329_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00626-3","author":"D Sepulveda-Falla","year":"2023","unstructured":"Sepulveda-Falla D (2023) Resistant and resilient mutations in protection against familial Alzheimer\u2019s disease: learning from nature. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-023-00626-3","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5329_CR165","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","volume":"490","author":"S Hoyer","year":"2004","unstructured":"Hoyer S (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490(1):115\u2013125. https:\/\/doi.org\/10.1016\/j.ejphar.2004.02.049","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"5329_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041289","volume":"21","author":"A Koren-Iton","year":"2020","unstructured":"Koren-Iton A, Salomon-Zimri S, Smolar A, Shavit-Stein E, Dori A, Chapman J, Michaelson DM (2020) Central and peripheral mechanisms in ApoE4-driven diabetic pathology. Int J Mol Sci 21(4):1289. https:\/\/doi.org\/10.3390\/ijms21041289","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5329_CR167","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang H-Y, Ahima RS, Craft S, Gandy S et al (2018) Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 14(3):168\u2013181. https:\/\/doi.org\/10.1038\/nrneurol.2017.185","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"5329_CR168","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13470","volume":"16","author":"Y Gao","year":"2023","unstructured":"Gao Y, Yu H, Liu Y, Xu Z, He B, Liu H, Wang Y, Zhang Y et al (2023) GSK-3\u03b2 activation mediates apolipoprotein E4-associated cognitive impairment in type 2 diabetes mellitus: a multicenter, cross-sectional study. J Diabetes 16(1):e13470. https:\/\/doi.org\/10.1111\/1753-0407.13470","journal-title":"J Diabetes"},{"key":"5329_CR169","doi-asserted-by":"publisher","unstructured":"Peila R, Rodriguez BL, Launer LJ, null n (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes 51(4):1256\u20131262. https:\/\/doi.org\/10.2337\/diabetes.51.4.1256","DOI":"10.2337\/diabetes.51.4.1256"},{"issue":"14","key":"5329_CR170","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1523\/jneurosci.5180-14.2015","volume":"35","author":"C-C Liu","year":"2015","unstructured":"Liu C-C, Hu J, Tsai C-W, Yue M, Melrose HL, Kanekiyo T, Bu G (2015) Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain. J Neurosci 35(14):5851\u20135859. https:\/\/doi.org\/10.1523\/jneurosci.5180-14.2015","journal-title":"J Neurosci"},{"key":"5329_CR171","doi-asserted-by":"publisher","DOI":"10.1038\/35096075","author":"P Cohen","year":"2001","unstructured":"Cohen P, Frame S (2001) The renaissance of GSK3. Nat Rev Mol Cell Biol. https:\/\/doi.org\/10.1038\/35096075","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"5329_CR172","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1567205016666190228120254","volume":"16","author":"S Salomon-Zimri","year":"2019","unstructured":"Salomon-Zimri S, Koren A, Angel A, Ben-Zur T, Offen D, Michaelson DM (2019) The role of MAPK\u2019s signaling in mediating ApoE4-driven pathology in vivo. Curr Alzheimer Res 16(4):281\u2013292. https:\/\/doi.org\/10.2174\/1567205016666190228120254","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"5329_CR173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/atvbaha.108.164863","volume":"28","author":"M Altenburg","year":"2008","unstructured":"Altenburg M, Arbones-Mainar J, Johnson L, Wilder J, Maeda N (2008) Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice. Arterioscler Thromb Vasc Biol 28(6):1\u201329. https:\/\/doi.org\/10.1161\/atvbaha.108.164863","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5329_CR174","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2025045","author":"C Lan","year":"2025","unstructured":"Lan C, Li Y, Weng Z, Pan W, Lin W, Jiang Z, Yang L, Shen X (2025) TLR4 mediates lipotoxic \u03b2-cell dysfunction by inhibiting the TMEM24\/PI3K\/AKT pathway. Acta Biochim Biophys Sin. https:\/\/doi.org\/10.3724\/abbs.2025045","journal-title":"Acta Biochim Biophys Sin"},{"issue":"9","key":"5329_CR175","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093165","volume":"21","author":"TT Nguyen","year":"2020","unstructured":"Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Van Giau V (2020) Type 3 diabetes and its role implications in Alzheimer\u2019s disease. Int J Mol Sci 21(9):3165. https:\/\/doi.org\/10.3390\/ijms21093165","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5329_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010778","volume":"24","author":"M Pires","year":"2023","unstructured":"Pires M, Rego AC (2023) Apoe4 and Alzheimer\u2019s disease pathogenesis-mitochondrial deregulation and targeted therapeutic strategies. Int J Mol Sci 24(1):778. https:\/\/doi.org\/10.3390\/ijms24010778","journal-title":"Int J Mol Sci"},{"key":"5329_CR177","doi-asserted-by":"publisher","unstructured":"Li Y, Caulfield TR, Macyczko JR, Wang N, Jia L, Shue F, Lu W, Zhao J et al (2022) Novel Wnt modulators for the treatment of Alzheimer\u2019s disease. Alzheimers Dement 18(S10). https:\/\/doi.org\/10.1002\/alz.063223","DOI":"10.1002\/alz.063223"},{"issue":"2","key":"5329_CR178","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1471-4159.2006.03867.x","volume":"98","author":"A Caruso","year":"2006","unstructured":"Caruso A, Motolese M, Iacovelli L, Caraci F, Copani A, Nicoletti F, Terstappen GC, Gaviraghi G et al (2006) Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. J Neurochem 98(2):364\u2013371. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03867.x","journal-title":"J Neurochem"},{"issue":"1","key":"5329_CR179","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12035-022-03065-1","volume":"60","author":"JR Macyczko","year":"2022","unstructured":"Macyczko JR, Wang N, Zhao J, Ren Y, Lu W, Ikezu TC, Zhao N, Liu C-C et al (2022) Suppression of Wnt\/\u03b2-catenin signaling is associated with downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer\u2019s disease. Mol Neurobiol 60(1):26\u201335. https:\/\/doi.org\/10.1007\/s12035-022-03065-1","journal-title":"Mol Neurobiol"},{"key":"5329_CR180","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02292-x","author":"C Zhou","year":"2025","unstructured":"Zhou C, Dong X, Li S, Xi Y, Liu Y, Qian X, Song Z, Zhou L et al (2025) Serine\/threonine\/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3\u03b2 sequestration-mediated Wnt\/\u03b2-catenin pathway hyperactivation. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-025-02292-x","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5329_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153545","volume":"225","author":"Q Li","year":"2021","unstructured":"Li Q, Wang G, Tao J, Chen W (2021) RNF6 promotes colorectal cancer invasion and migration via the Wnt\/\u03b2-catenin pathway by inhibiting GSK3\u03b2 activity. Pathology - Research and Practice 225(1):153545. https:\/\/doi.org\/10.1016\/j.prp.2021.153545","journal-title":"Pathology - Research and Practice"},{"key":"5329_CR182","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.3c00728","author":"W Wei","year":"2024","unstructured":"Wei W, Sun H, Yang B, Song E, Song Y (2024) Coronal ApoE protein combines with LRP1 to inactivate GSK3\u03b2 that mitigates silica nanoparticle-induced brain lesion. ACS Chem Neurosci. https:\/\/doi.org\/10.1021\/acschemneuro.3c00728","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"5329_CR183","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1038\/s41467-021-23762-0","volume":"12","author":"NF Fitz","year":"2021","unstructured":"Fitz NF, Nam KN, Wolfe CM, Letronne F, Playso BE, Iordanova BE, Kozai TDY, Biedrzycki RJ et al (2021) Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer\u2019s disease. Nat Commun 12(1):3416. https:\/\/doi.org\/10.1038\/s41467-021-23762-0","journal-title":"Nat Commun"},{"issue":"27","key":"5329_CR184","doi-asserted-by":"publisher","first-page":"24674","DOI":"10.1074\/jbc.m102036200","volume":"276","author":"TM Lewin","year":"2001","unstructured":"Lewin TM, Kim JH, Granger DA, Vance JE, Coleman RA (2001) Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J Biol Chem 276(27):24674\u201324679. https:\/\/doi.org\/10.1074\/jbc.m102036200","journal-title":"J Biol Chem"},{"issue":"3","key":"5329_CR185","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/jcb.22996","volume":"112","author":"YS Chang","year":"2011","unstructured":"Chang YS, Tsai CT, Huangfu CA, Huang WY, Lei HY, Lin CF, Su IJ, Chang WT et al (2011) ACSL3 and GSK-3\u03b2 are essential for lipid upregulation induced by endoplasmic reticulum stress in liver cells. J Cell Biochem 112(3):881\u2013893. https:\/\/doi.org\/10.1002\/jcb.22996","journal-title":"J Cell Biochem"},{"issue":"1","key":"5329_CR186","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbamcr.2003.10.018","volume":"1644","author":"Y Fujimoto","year":"2004","unstructured":"Fujimoto Y, Itabe H, Sakai J, Makita M, Noda J, Mori M, Higashi Y, Kojima S et al (2004) Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1644(1):47\u201359. https:\/\/doi.org\/10.1016\/j.bbamcr.2003.10.018","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"5329_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07185-7","author":"MS Haney","year":"2024","unstructured":"Haney MS, P\u00e1lovics R, Munson CN, Long C, Johansson PK, Yip O, Dong W, Rawat E et al (2024) APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature. https:\/\/doi.org\/10.1038\/s41586-024-07185-7","journal-title":"Nature"},{"key":"5329_CR188","doi-asserted-by":"publisher","DOI":"10.1021\/acs.est.2c06330","author":"Y-C Xu","year":"2023","unstructured":"Xu Y-C, Pantopoulos K, Zheng H, Zito E, Zhao T, Tan X-Y, Wei X-L, Song Y-F et al (2023) Phosphorus overload promotes hepatic lipolysis by suppressing GSK3\u03b2-dependent phosphorylation of PPAR\u03b1 at Ser84 and Thr265 in a freshwater teleost. Environ Sci Technol. https:\/\/doi.org\/10.1021\/acs.est.2c06330","journal-title":"Environ Sci Technol"},{"issue":"1","key":"5329_CR189","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12974-016-0598-3","volume":"13","author":"Y Qian","year":"2016","unstructured":"Qian Y, Yin J, Hong J, Li G, Zhang B, Liu G, Wan Q, Chen L (2016) Neuronal seipin knockout facilitates A\u03b2-induced neuroinflammation and neurotoxicity via reduction of PPAR\u03b3 in hippocampus of mouse. J Neuroinflammation 13(1):145\u2013145. https:\/\/doi.org\/10.1186\/s12974-016-0598-3","journal-title":"J Neuroinflammation"},{"issue":"S1","key":"5329_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/alz.092389","volume":"20","author":"DJ Zajac","year":"2025","unstructured":"Zajac DJ, Xu J, Cheng F (2025) SnRNA-seq analysis of human brains suggests cell type-specific synergistic effects of APOE4 and TREM2-R47H and potential drug targets in Alzheimer\u2019s disease. Alzheimers Dement 20(S1):e092389. https:\/\/doi.org\/10.1002\/alz.092389","journal-title":"Alzheimers Dement"},{"issue":"4","key":"5329_CR191","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70120","volume":"21","author":"EE Lietzke","year":"2025","unstructured":"Lietzke EE, Saeb D, Aldrich EC, Bruce KD, Sprenger KG (2025) Synergistic reduction in interfacial flexibility of TREM2R47H and ApoE4 may underlie AD pathology. Alzheimers Dement 21(4):e70120. https:\/\/doi.org\/10.1002\/alz.70120","journal-title":"Alzheimers Dement"},{"key":"5329_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.687157","volume":"15","author":"Z Wei","year":"2021","unstructured":"Wei Z, Koya J, Reznik SE (2021) Insulin resistance exacerbates Alzheimer\u2019s disease via multiple mechanisms. Front Neurosci 15:687157. https:\/\/doi.org\/10.3389\/fnins.2021.687157","journal-title":"Front Neurosci"},{"issue":"1","key":"5329_CR193","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12974-018-1313-3","volume":"15","author":"EA Newcombe","year":"2018","unstructured":"Newcombe EA, Camats-Perna J, Silva ML, Valmas N, Huat TJ, Medeiros R (2018) Inflammation: the link between comorbidities, genetics, and Alzheimer\u2019s disease. J Neuroinflammation 15(1):276. https:\/\/doi.org\/10.1186\/s12974-018-1313-3","journal-title":"J Neuroinflammation"},{"issue":"13","key":"5329_CR194","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.2174\/1389450122666210118150313","volume":"22","author":"CC Kandar","year":"2021","unstructured":"Kandar CC, Sen D, Maity A (2021) Anti-inflammatory potential of GSK-3 inhibitors. Curr Drug Targets 22(13):1464\u20131476. https:\/\/doi.org\/10.2174\/1389450122666210118150313","journal-title":"Curr Drug Targets"},{"key":"5329_CR195","doi-asserted-by":"publisher","first-page":"116065","DOI":"10.1016\/j.ejmech.2023.116065","volume":"265","author":"Z Cheng","year":"2023","unstructured":"Cheng Z, Han T, Yao J, Wang K, Dong X, Yu F, Huang H, Han M et al (2023) Targeting glycogen synthase kinase-3\u03b2 for Alzheimer\u2019s disease: recent advances and future prospects. Eur J Med Chem 265:116065. https:\/\/doi.org\/10.1016\/j.ejmech.2023.116065","journal-title":"Eur J Med Chem"},{"key":"5329_CR196","doi-asserted-by":"publisher","DOI":"10.1038\/srep45701","author":"I Gameiro","year":"2017","unstructured":"Gameiro I, Michalska P, Tenti G, Cores \u00c1, Buendia I, Rojo AI, Georgakopoulos ND, Hern\u00e1ndez-Guijo JM et al (2017) Discovery of the first dual GSK3\u03b2 inhibitor\/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer\u2019s disease. Sci Rep. https:\/\/doi.org\/10.1038\/srep45701","journal-title":"Sci Rep"},{"issue":"1","key":"5329_CR197","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1567205011310010014","volume":"10","author":"M Andrade Nunes","year":"2012","unstructured":"Andrade Nunes M, Araujo Viel T, Sousa Buck H (2012) Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer\u2019s disease. Curr Alzheimer Res 10(1):104\u2013107. https:\/\/doi.org\/10.2174\/1567205011310010014","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"5329_CR198","doi-asserted-by":"publisher","DOI":"10.3390\/nu12041032","volume":"12","author":"RN Thota","year":"2020","unstructured":"Thota RN, Rosato JI, Dias CB, Burrows TL, Martins RN, Garg ML (2020) Dietary supplementation with curcumin reduce circulating levels of glycogen synthase kinase-3\u03b2 and islet amyloid polypeptide in adults with high risk of type 2 diabetes and Alzheimer\u2019s disease. Nutrients 12(4):1032. https:\/\/doi.org\/10.3390\/nu12041032","journal-title":"Nutrients"},{"issue":"3","key":"5329_CR199","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/alz.13532","volume":"20","author":"ME Riviere","year":"2024","unstructured":"Riviere ME, Langbaum JB, Turner RS, Rinne JO, Sui Y, Cazorla P, Ricart J, Meneses K et al (2024) Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE \u03b54 homozygotes. Alzheimers Dement 20(3):1839\u20131850. https:\/\/doi.org\/10.1002\/alz.13532","journal-title":"Alzheimers Dement"},{"issue":"8","key":"5329_CR200","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1074\/jbc.m111.276162","volume":"287","author":"H-K Chen","year":"2012","unstructured":"Chen H-K, Liu Z, Meyer-Franke A, Brodbeck J, Miranda RD, McGuire JG, Pleiss MA, Ji Z-S et al (2012) Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem 287(8):5253\u20135266. https:\/\/doi.org\/10.1074\/jbc.m111.276162","journal-title":"J Biol Chem"},{"key":"5329_CR201","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01353-z","author":"AC Valencia-Olvera","year":"2023","unstructured":"Valencia-Olvera AC, Balu D, Bellur S, McNally T, Saleh Y, Pham D, Ghura S, York J et al (2023) A novel apoE-mimetic increases brain apoE levels, reduces A\u03b2 pathology and improves memory when treated before onset of pathology in male mice that express APOE3. Alzheimers Res Ther. https:\/\/doi.org\/10.1186\/s13195-023-01353-z","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"5329_CR202","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ymthe.2024.03.024","volume":"32","author":"RJ Jackson","year":"2024","unstructured":"Jackson RJ, Keiser MS, Meltzer JC, Fykstra DP, Dierksmeier SE, Hajizadeh S, Kreuzer J, Morris R et al (2024) APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease. Mol Ther 32(5):1373\u20131386. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.024","journal-title":"Mol Ther"},{"issue":"1","key":"5329_CR203","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s40265-024-02067-8","volume":"84","author":"JA Hey","year":"2024","unstructured":"Hey JA, Abushakra S, Blennow K, Reiman EM, Hort J, Prins ND, Sheardova K, Kesslak P, Shen L, Zhu X, Albayrak A, Paul J, Schaefer JF, Power A, Tolar M (2024) Effects of oral ALZ-801\/valiltramiprosate on plasma biomarkers, brain hippocampal volume, and cognition: results of 2-year single-arm, open-label, phase 2 trial in APOE4 carriers with early Alzheimer\u2019s disease. Drugs 84(1):811\u2013823. https:\/\/doi.org\/10.1007\/s40265-024-02067-8","journal-title":"Drugs"},{"key":"5329_CR204","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01441-8","author":"LS Honig","year":"2024","unstructured":"Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, Giorgi L, Gee M et al (2024) Updated safety results from phase 3 lecanemab study in early Alzheimer\u2019s disease. Alzheimer\u2019s Research & Therapy. https:\/\/doi.org\/10.1186\/s13195-024-01441-8","journal-title":"Alzheimer's Research & Therapy"},{"issue":"7","key":"5329_CR205","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.clnu.2019.10.017","volume":"39","author":"Q Xu","year":"2020","unstructured":"Xu Q, Zhang Y, Zhang X, Liu L, Zhou B, Mo R, Li Y, Li H et al (2020) Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer\u2019s disease patients with APOE4-\/-: a double-blind, randomized, placebo-controlled crossover trial. Clin Nutr 39(7):2092\u20132105. https:\/\/doi.org\/10.1016\/j.clnu.2019.10.017","journal-title":"Clin Nutr"},{"issue":"8","key":"5329_CR206","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jamaneurol.2024.1755","volume":"81","author":"PT Nguyen Ho","year":"2024","unstructured":"Nguyen Ho PT, Hoepel SJW, Rodriguez-Ayllon M, Luik AI, Vernooij MW, Neitzel J (2024) Sleep, 24-hour activity rhythms, and subsequent amyloid-\u03b2 pathology. JAMA Neurol 81(8):824\u2013834. https:\/\/doi.org\/10.1001\/jamaneurol.2024.1755","journal-title":"JAMA Neurol"},{"issue":"6","key":"5329_CR207","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003597","volume":"18","author":"X Jin","year":"2021","unstructured":"Jin X, He W, Zhang Y, Gong E, Niu Z, Ji J, Li Y, Zeng Y et al (2021) Association of APOE \u03b54 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: a cross-sectional study. PLoS Med 18(6):e1003597. https:\/\/doi.org\/10.1371\/journal.pmed.1003597","journal-title":"PLoS Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05329-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:02:57Z","timestamp":1762977777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05329-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":207,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5329"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05329-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"32"}}